Surveillance for neuraminidase inhibitor resistance among human influenza a and B viruses circulating worldwide from 2004 to 2008
Sheu TG, et al., 2008. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 52 (9): 3284-3292.
4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza a and B viruses in vitro
Woods JM, et al., 1993. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob Agents Chemother 37 (7): 1473-1479.
Laninamivir and its prodrug, CS-8958: Long-acting neuraminidase inhibitors for the treatment of influenza
Yamashita M,. 2010. Laninamivir and its prodrug, CS-8958: Long-acting neuraminidase inhibitors for the treatment of influenza. Antivir Chem Chemother 21 (2): 71-84.
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration
Kubo S, Tomozawa T, Kakuta M, Tokumitsu A, Yamashita M,. 2010. Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration. Antimicrob Agents Chemother 54 (3): 1256-1264.
Supply of neuraminidase inhibitors related to reduced influenza a (H1N1) mortality during the 2009-2010 H1N1 pandemic: An ecological study
Miller PE, et al., 2012. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: An ecological study. PloS One 7 (9): e43491.
BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design
Babu YS, et al., 2000. BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J Med Chem 43 (19): 3482-3486.
The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir
Arya V, Carter WW, Robertson SM,. 2010. The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir. Clin Pharmacol Ther 88 (5): 587-589.
Pharmacokinetics of oseltamivir: An oral antiviral for the treatment and prophylaxis of influenza in diverse populations
Davies BE,. 2010. Pharmacokinetics of oseltamivir: An oral antiviral for the treatment and prophylaxis of influenza in diverse populations. J Antimicrob Chemother 65 (Suppl 2): ii5-ii10.
Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A
Schade D, et al., 2014. Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A. J Med Chem 57 (3): 759-769.
Enabling the intestinal absorption of highly polar antiviral agents: Ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir
Miller JM, Dahan A, Gupta D, Varghese S, Amidon GL,. 2010. Enabling the intestinal absorption of highly polar antiviral agents: Ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir. Mol Pharm 7 (4): 1223-1234.
Metabolism of N-hydroxyguanidines (N-hydroxydebrisoquine) in human and porcine hepatocytes: Reduction and formation of glucuronides
Froehlich AK, Girreser U, Clement B,. 2005. Metabolism of N-hydroxyguanidines (N-hydroxydebrisoquine) in human and porcine hepatocytes: Reduction and formation of glucuronides. Drug Metab Dispos 33 (10): 1532-1537.
Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Similarity with the oxidation of arginine to citrulline and nitric oxide
Clement B, Schultze-Mosgau MH, Wohlers H,. 1993. Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Similarity with the oxidation of arginine to citrulline and nitric oxide. Biochem Pharmacol 46 (12): 2249-2267.
Microsomal catalyzed N-hydroxylation of guanabenz and reduction of the N-hydroxylated metabolite: Characterization of the two reactions and genotoxic potential of guanoxabenz
Clement B, Demesmaeker M, Linne S,. 1996. Microsomal catalyzed N-hydroxylation of guanabenz and reduction of the N-hydroxylated metabolite: Characterization of the two reactions and genotoxic potential of guanoxabenz. Chem Res Toxicol 9 (4): 682-688.
Stereoselective synthesis of 1,2-diols by the cycloadditive strategy: Total synthesis of (±)-exo-brevicomin and (±)- and (-)-pestalotin
Zhang J, Curran DP,. 1991. Stereoselective synthesis of 1,2-diols by the cycloadditive strategy: Total synthesis of (±)-exo-brevicomin and (±)- and (-)-pestalotin. J Chem Soc Perkin 1 (11): 2627-2631.
Novel neuraminidase inhibitors: Identification, biological evaluation and investigations of the binding mode
Kirchmair J, et al., 2011. Novel neuraminidase inhibitors: Identification, biological evaluation and investigations of the binding mode. Future Med Chem 3 (4): 437-450.
A DNA transfection system for generation of influenza a virus from eight plasmids
Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG,. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97 (11): 6108-6113.
A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1
Schmidtke M, Schnittler U, Jahn B, Dahse H, Stelzner A,. 2001. A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1. J Virol Methods 95 (1-2): 133-143.
S-2-naphthylmethyl thioacetimidste hydrobromide: A new odorless reagent for the mild synthesis of substituted acetamidines
Shearer BG, Oplinger JA, Lee S,. 1997. S-2-naphthylmethyl thioacetimidste hydrobromide: A new odorless reagent for the mild synthesis of substituted acetamidines. Tetrahedron Lett 38 (2): 179-182.
Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza a viruses isolated in Germany from 2001 to 2005/2006
Bauer K, Richter M, Wutzler P, Schmidtke M,. 2009. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006. Antivir Res 82 (1): 34-41.
Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai
Grienke U, et al., 2010. Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai. J Med Chem 53 (2): 778-786.
